Johnson & Johnson Issues Dr. Paul Janssen Award for Biomedical Research Call for Nominations

Thu Jan 10, 2013 9:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link

NEW BRUNSWICK, N.J., Jan. 10, 2013 /PRNewswire/ -- The Dr.  Paul Janssen  Award
for Biomedical Research today opens its 2013 call for nominations. This
prestigious award recognizes individuals whose scientific research has made, or
has the potential to make, significant transformational contributions toward the
improvement of human health. Nominations will be accepted until  February 28,
2013  at  for consideration by an independent
selection committee of world renowned scientists. A  $100,000  cash prize will
be awarded to the scientist or group of scientists receiving the Award.

The Dr.  Paul Janssen  Award for Biomedical Research honors Dr.  Paul Janssen 
(1926-2003), who is widely recognized as one of the most productive scientists
of the 20th century. Known throughout the scientific community as "Dr. Paul,"
Janssen was responsible for breakthrough treatments in disease areas including
pain management, psychiatry, infectious disease and gastroenterology, and
founded Janssen Pharmaceutica, N.V., a Johnson & Johnson Company.  

"Johnson & Johnson is pleased to recognize the ground-breaking research being
done by dedicated and talented scientists around the world," said  Paul
Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman,
Pharmaceuticals, Johnson & Johnson. "Through the Dr.  Paul Janssen  Award for
Biomedical Research, we honor the inspirational legacy of Dr. Paul, applaud
today's researchers, and recognize the potential of scientific and technological
advances to transform human health."

In 2012, the Award was presented to  Victor Ambros, Ph.D., of  University of
Massachusetts Medical School, and  Gary Ruvkun, Ph.D., of  Massachusetts 
General Hospital and  Harvard Medical School, for their co-discovery of
microRNAs as central regulators of gene expression and development. Their
discovery opened new fields of research and has implications for the development
of diagnostic tools and medicines.

"Scientific innovation has proven its tremendous value to individuals and
society by extending and improving lives," said Dr. Stoffels. "We must continue
to celebrate and reward researchers and innovators whose passion and ideas help
advance new healthcare solutions that address the needs of people around the

Previous Award winners include  Napoleone Ferrara, M.D., Genentech Fellow; 
Anthony S. Fauci, M.D., director, National Institute of Allergy and Infectious
Diseases (NIAID);  Erik De Clercq, M.D., Ph.D., chairman, Department of
Microbiology and Immunology, Medical School at the  Catholic University of
Leuven;  Axel Ullrich, Ph.D., director, Department of Molecular Biology, Max
Planck Institute of Biochemistry in  Germany; Professor  Marc Feldmann, FMedSci,
FAA, FRS, and Emeritus Professor Sir  Ravinder Maini, FRCP, FMedSci, FRS, of the
Kennedy Institute of Rheumatology, Imperial College London; and  Craig Mello,
Ph.D., Nobel Laureate, of the Howard Hughes Medical Institute and  University of
Massachusetts Medical School.  

Beyond the passion and creativity Dr.  Paul Janssen  demonstrated in the
laboratory, he also inspired and mentored many young scientific leaders who went
on to great achievements in addressing medical need.

"As in past years, we look forward to selecting a 2013 Dr.  Paul Janssen  Award
winner(s) from among the nominations of worthy individuals in research
institutions and companies around the world, who has significantly improved
human health through dedication to the advancement of science and medicine,"
said  Craig Mello, Ph.D.,  Howard Hughes Medical Institute Investigator  and
Professor, Program in Molecular Medicine,  University of Massachusetts Medical
School  and 2013 chair of the Dr.  Paul Janssen  Award Selection Committee.

The 2013 Dr.  Paul Janssen  Award winner will be announced in spring 2013.

About The Dr.  Paul Janssen  Award for Biomedical Research
Established by Johnson & Johnson, The Dr.  Paul Janssen  Award salutes the most
passionate and creative scientists in basic or clinical research whose
scientific achievements have made, or have strong potential to make, a
measurable impact on human health. The Dr.  Paul Janssen  Award is named for Dr.
 Paul Janssen, who founded Janssen Pharmaceutica, N.V., in 1953. Known to his
colleagues as "Dr. Paul," Janssen was one of the 20th century's most gifted and
passionate researchers, a physician-scientist who helped save millions of lives
through his contribution to the discovery and development of more than 80
medicines, four of which remain on the World Health Organization's list of
essential medicines. In 1961, Janssen Pharmaceutica, N.V. joined the Johnson &
Johnson Family of Companies. Janssen's legacy continues to inspire Johnson &
Johnson and its commitment to finding innovative cures for unmet medical needs.
Visit  for more information.

About Johnson & Johnson
Caring for the world, one person at a time...inspires and unites the people of
Johnson & Johnson (NYSE: JNJ). We embrace research and science - bringing
innovative ideas, products and services to advance the health and well-being of
people. Our approximately 129,000 employees at more than 250 Johnson & Johnson
companies work with partners in healthcare to touch the lives of over a billion
people every day, throughout the world.

Seema Kumar
Johnson & Johnson Services, Inc.
908-218-6460 or

Diane Pressman
Janssen Global Services, LLC
908-927-6171 or

Frederik Wittock
Janssen Global Services, LLC
+32 14 60 57 24 or

SOURCE  Johnson & Johnson
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.